18 May 2013
Keywords: Alpharma, Promotion, False claims, Kadian, Pain drug
Article | 17 March 2010
US drugmaker Alpharma, a subsidiary of King Pharmaceuticals, has agreed to pay $42.5 million to resolve False Claims Act allegations in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2010
17 May 2013
© 2013 thepharmaletter.com